Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRYWladimir Mauhin, Olivier Benvéniste, Claire Douillard et al.|Orphanet Journal of Rare Diseases|2018Cited by 33
Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patientsElisa Masat, Yann Péréon, Pascal Laforêt et al.|Scientific Reports|2016Cited by 32
Cytokine and chemokine profiling shows rapid activation of the immune system following enzyme replacement therapy in Pompe diseaseElisa Masat, Federico Mingozzi, Pascal Laforêt et al.|Neuromuscular Disorders|2015Cited by 0